OHI FY 2012 Earnings Report — Omega Healthcare Investors, Inc. Revenue & Financial Results | Market Cap Arena

Omega Healthcare Investors, Inc.OHI

FY 2012 Earnings

Reported February 28, 2013

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2012	Prior Q	FY 2011	QoQ Change	YoY Change
Revenue	$350M	—	$292M	—	19.9%
Op. Income	$215M	—	$138M	—	56.0%
Gross Margin	100.0%	—	99.8%	—	0.2pp
Net Margin	34.4%	—	18.0%	—	16.4pp
EPS (Diluted)	$1.12	—	$0.46	—	143.5%
Free Cash Flow	$208M	—	$63M	—	228.1%

Revenue Flow

Item	Amount
REVENUE	$350M
Cost of Revenue	$0
GROSS PROFIT	$350M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$21M
SG&A Expenses	$21M
Other Expenses	$114M
Operating Expenses	$135M
Cost & Expenses	$135M
OPERATING INCOME	$215M
Interest Income	$29.0K
Interest Expense	$106M
Other Income/Expenses	-$94M
INCOME BEFORE TAX	$121M
Income Tax Expense	$0
Net Income from Continuing Ops	$121M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$121M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$121M
D&A	$113M
EBIT	$227M
EBITDA	$340M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$350M
Cost of Revenue	$0
GROSS PROFIT	$350M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$21M
SG&A Expenses	$21M
Other Expenses	$114M
Operating Expenses	$135M
Cost & Expenses	$135M
OPERATING INCOME	$215M
Interest Income	$29.0K
Interest Expense	$106M
Other Income/Expenses	-$94M
INCOME BEFORE TAX	$121M
Income Tax Expense	$0
Net Income from Continuing Ops	$121M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$121M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$121M
D&A	$113M
EBIT	$227M
EBITDA	$340M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$121M
Depreciation & Amortization	$113M
Stock-Based Compensation	$6M
Deferred Income Tax	$0
Other Non-Cash Items	-$991.0K
Change in Working Capital	-$24M
OPERATING CASH FLOW	$208M
Capital Expenditure	$0
Acquisitions (Net)	$0
Purchases of Investments	-$10M
Sales/Maturities of Investments	$15M
Other Investing Activities	-$396M
NET CASH FROM INVESTING	-$391M
Net Debt Issuance	$195M
Common Stock Repurchased	$0
Common Dividends Paid	-$182M
Other Financing Activities	$94M
NET CASH FROM FINANCING	$184M
FREE CASH FLOW	$208M
Net Change in Cash	$1M

Balance Sheet

Item	Amount
Cash & Equivalents	$2M
Short-Term Investments	$0
Net Receivables	$364M
Inventory	$0
Other Current Assets	$38M
TOTAL CURRENT ASSETS	$403M
PP&E (Net)	$0
Goodwill	$0
Intangible Assets	$0
Long-Term Investments	$47M
Tax Assets	$0
Other Non-Current Assets	$2.5B
TOTAL NON-CURRENT ASSETS	$2.6B
TOTAL ASSETS	$3.0B
Account Payables	$0
Short-Term Debt	$158M
Deferred Revenue	$0
Other Current Liabilities	$0
TOTAL CURRENT LIABILITIES	$304M
Long-Term Debt	$1.7B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$0
Other Non-Current Liabilities	$0
TOTAL NON-CURRENT LIABILITIES	$1.7B
TOTAL LIABILITIES	$2.0B
Common Stock	$11M
Additional Paid-In Capital	$1.7B
Retained Earnings	-$665M
Treasury Stock	$0
Accum. Other Comp. Income	$0
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$1.0B
Minority Interest	$0
TOTAL EQUITY	$1.0B
TOTAL LIABILITIES & EQUITY	$3.0B
Total Debt	$1.8B
Net Debt	$1.8B